Phase II Theophylline Radioimmunoassay
by Medical & Scientific Designs, Inc.
510(k) K833789
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK833789 | Date24 Jan 1984 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LCA
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.3880
- Advisory Committee
- Clinical Toxicology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
The Phase II Theophylline Radioimmunoassay is a Class II medical device used for the quantitative determination of theophylline in human serum or plasma. This radioimmunoassay measures theophylline levels, which is a medication used to treat respiratory diseases such as asthma and COPD.
The device is supplied as a kit and is intended for single-use in clinical laboratory settings. It is not MRI compatible and requires storage according to the manufacturer's instructions. The device received FDA 510(k) clearance with K number K833789 and is classified under product code LCA, regulated under 21 CFR 862.3880.
Other devices from Medical & Scientific Designs, Inc.
Questions
AI-generated answers, 21 Sep 2026
What is the Phase II Theophylline Radioimmunoassay used for?
The Phase II Theophylline Radioimmunoassay is a Class II medical device used for the quantitative determination of theophylline levels in human serum or plasma. Theophylline is a medication commonly used to treat respiratory diseases such as asthma and COPD.
How is the Phase II Theophylline Radioimmunoassay supplied?
The device is supplied as a kit and is intended for single-use in clinical laboratory settings. It requires storage according to the manufacturer's instructions and is not MRI compatible.
What is the regulatory status of the Phase II Theophylline Radioimmunoassay?
The device received FDA 510(k) clearance with K number K833789 and is classified under product code LCA, regulated under 21 CFR 862.3880. It was determined to be substantially equivalent to other devices on the market.
What are the specifications of the Phase II Theophylline Radioimmunoassay?
The device is a radioimmunoassay kit designed for quantitative determination of theophylline in human serum or plasma. It is a single-use device intended for clinical laboratory settings and requires proper storage as per manufacturer instructions.